Ever Supreme Bio Technology Co., Ltd (6712.TWO)
TWD 164.0
(-3.53%)
TWD 164.0
(-3.53%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.89 Million TWD | -66.98% |
| 2022 | 17.86 Million TWD | -48.1% |
| 2021 | 34.41 Million TWD | -20.35% |
| 2020 | 43.2 Million TWD | 950.55% |
| 2019 | 4.11 Million TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 8.53 Million TWD | -11.67% |
| 2024 Q1 | 9.66 Million TWD | 63.82% |
| 2023 Q4 | 5.89 Million TWD | -33.78% |
| 2023 FY | 5.89 Million TWD | -66.98% |
| 2023 Q3 | 8.9 Million TWD | -24.63% |
| 2023 Q2 | 11.81 Million TWD | -20.09% |
| 2023 Q1 | 14.78 Million TWD | 228.45% |
| 2022 FY | 17.86 Million TWD | -48.1% |
| 2022 Q4 | 4.5 Million TWD | 0.0% |
| 2021 FY | 34.41 Million TWD | -20.35% |
| 2020 FY | 43.2 Million TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 97.705% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 96.612% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | 45.379% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 98.536% |
| Level Biotechnology Inc. | 13.5 Million TWD | 56.318% |
| Sagittarius Life Science Corp | 13.32 Million TWD | 55.731% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 93.913% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 99.214% |
| GlycoNex Incorporation | 900 Thousand TWD | -555.333% |
| VBI | - TWD | -Infinity% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 98.158% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -178.997% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 97.92% |
| Visgeneer Inc. | 158.6 Million TWD | 96.281% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 99.188% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -8.599% |
| Neith Corporation | 3.54 Million TWD | -66.563% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -403.672% |
| Enimmune corporation | 45.73 Million TWD | 87.104% |
| TaiRx, Inc. | 12.28 Million TWD | 51.994% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| EirGenix Inc. | 465.16 Million TWD | 98.732% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 89.867% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 98.493% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -577.931% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 54.95% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 92.856% |
| RBC Bioscience Corporation | 487.36 Million TWD | 98.79% |
| BiOptic Inc. | 93.19 Million TWD | 93.672% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -326.464% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -64.198% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -996.283% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 58.97% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 99.135% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.701% |
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 94.801% |
| Lin BioScience, Inc. | 42.87 Million TWD | 86.243% |
| NaviFUS Corp. | 32.69 Million TWD | 81.959% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 98.586% |
| Sinew Pharma Inc. | 6.46 Million TWD | 8.756% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 78.253% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 96.993% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 53.228% |
| AP Biosciences Inc | 82.07 Million TWD | 92.814% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.797% |
| 3D Global Biotech Inc. | 10.37 Million TWD | 43.174% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 95.915% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 99.589% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 98.518% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -35.462% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | 26.007% |
| TCI GENE Inc. | 6.79 Million TWD | 13.201% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | 29.094% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | 38.569% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 97.804% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | 44.786% |
| PharmaEngine, Inc. | 14.8 Million TWD | 60.173% |
| Savior Lifetec Corporation | 270.37 Million TWD | 97.819% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 92.103% |
| OBI Pharma, Inc. | 501.05 Million TWD | 98.823% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 82.673% |
| Acepodia, Inc. | 273.81 Million TWD | 97.846% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 71.17% |